Clinical use of mizoribine (Bredinin) and pharmacologic monitoring assessment in renal transplantation.
Zaoui
P
P
Transplantation Unit, CHU Grenoble, France.
Serre-Debeauvais
F
F
Bayle
F
F
Bessard
G
G
Pintar
P
P
Deteix
P
P
Janbon
B
B
Vialtel
P
P
D003404:Creatinine / Q000097:blood; D016903:Drug Monitoring; D005500:Follow-Up Studies; D006207:Half-Life; D006801:Humans; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D012263:Ribonucleosides / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D013997:Time Factors
D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D003404:Creatinine